...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: 32 cents

I don't understand the recent placements at $1.50....

I also don't understand why this trades at 32 cents on the pinks....

I guess there is not much I understand about the price of Zenith (or RVX).

Share
New Message
Please login to post a reply